Europe — EMA

Ondansetrón Ratio (Ondansetron)

Ondansetron, the active ingredient in Ondansetrón Ratio, is a 5-HT3 receptor antagonist presented as a unknown/unknown for unknown use.

Ondansetron

Request sourcing

Pack/s

What is Ondansetron?

Ondansetron, the active ingredient in Ondansetrón Ratio, is a 5-HT3 receptor antagonist presented as a unknown/unknown for unknown use. It treats and prevents nausea and vomiting associated with chemotherapy, radiation therapy, and surgery. GNH USA supplies Ondansetrón Ratio as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

GNH USA supplies Ondansetrón Ratio as a licensed, GDP‑compliant ...

What is Ondansetron used for?

Ondansetron works … ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...

- ...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →